Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Viventia Biotech and Acceptys enter option agreement for anticancer antibodies

Aug. 23, 2004

Taxotere approved for early-stage breast cancer

Aug. 23, 2004

New phase I/II study of CG-7870 plus Taxotere for prostate cancer

Aug. 23, 2004

New EGFR inhibitors identified by Ariad scientists

Aug. 23, 2004

Fast track status for temsirolimus for first-line treatment of advanced RCC

Aug. 19, 2004

MediGene acquires anticancer drugs and technology of Munich Biotech

Aug. 19, 2004

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Swiss approval for Femara as extended adjuvant treatment

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...